Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Sylphar launches oral treatments in Boots

Belgian skincare manufacturer Sylphar has launched its mouth ulcer and cold sore treatments in Boots stores.

 

Herpatch Mouth Ulcer Gel and Herpatch Cold Sore Prevention Sticks have both been available to buy in Boots stores nationwide from last month, Sylphar said.

 

The gel, which contains hyaluronic acid, zinc and aloe vera, creates an “adhesive physical barrier” over ulcers to stop irritants entering the infected tissue, it said. The alcohol-free product was suitable for adults, children and pregnant women and came in a “handy pump dispenser”, the manufacturer said.

 

The cold sore balm was a “pioneering” moisturising treatment that blocked “triggers” that could lead to a cold sore blister, such as sunlight, Sylphar said. Sylphar said it planned to launch the treatments in other pharmacies in the future, but had not set a date.

 

Herpatch Mouth Ulcer Gel retails at £7.00 and the Cold Sore Prevention Stick at £4.99.

 

Contact FDD International on 01344 878180

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel